Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease

被引:275
|
作者
Lomer, MCE
Thompson, RPH
Powell, JJ
机构
[1] St Thomas Hosp, Rayne Inst, Gastrointestinal Lab, London SE1 7EH, England
[2] Kings Coll London, Dept Nutr, London SE1 8WA, England
关键词
dietary microparticles; Crohn's disease;
D O I
10.1079/PNS2001134
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Crohn's disease is a modem Western disease characterised by transmural inflammation of the gastrointestinal tract. It is of unknown aetiology, but evidence suggests that it results from a combination of genetic predisposition and environmental factors. Bacterial-sized microparticles (0.1-1.0 mum) are potent adjuvants in model antigen-mediated immune responses and are increasingly associated with disease. Microparticles of TiO2 and aluminosilicate accumulate in macrophages of human gut-associated lymphoid tissue where the earliest signs of lesions in Crohn's disease are observed. Dietary microparticles are of endogenous or exogenous origin. Endogenous microparticles dominate and are calcium phosphate (most probably hydroxyapatite), which precipitates in the lumen of the mid-distal gastrointestinal tract due to secretion of Ca and phosphate in the succus entericus, Exogenous dietary microparticles are contaminants (soil and/or dust) and food additives. TiO2, for example, is a food colourant, and alummosilicates are anti-caking agents, although some aluminosilicates occur as natural contaminants. Food additives alone account for ingestion of approximately 10(12) particles/person per d. Possible mechanisms for the role of exogenous and endogenous dietary microparticles in promoting toleragenic or immune responses of gastrointestinal mucosal phagocytosis are discussed. In a double-blind randomised pilot study we have shown that a diet low in Ca and exogenous microparticles appears to alleviate the symptoms of ileal Crohn's disease, with a significant (P = 0.002) improvement in the Crohn's disease activity index. A multi-centre trial and further mechanistic studies at the cellular level are underway.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [41] Response to strict and liberalized specific carbohydrate diet in pediatric Crohn's disease
    Jennifer C Burgis
    Kaylie Nguyen
    KT Park
    Kenneth Cox
    World Journal of Gastroenterology, 2016, 22 (06) : 2111 - 2117
  • [42] Crohn's disease as an immune deficiency?
    Coulombe, Francois
    Behr, Marcel A.
    LANCET, 2009, 374 (9692): : 769 - 770
  • [43] The association of faecal calprotectin level and combined mucosal and transmural healing in patients with Crohn's disease
    Noh, S.
    Oh, E. H.
    Park, S. H.
    Lee, J. B.
    Kim, J. Y.
    Park, J. C.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Yang, D. H.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S68 - S70
  • [44] Association of TRAP1 with infliximab-induced mucosal healing in Crohn's disease
    Park, Sang Hyoung
    Hong, Myunghee
    Lee, Ho-Su
    Ye, Byong Duk
    Hwang, Sung Wook
    Jung, Seulgi
    Baek, Jiwon
    Moon, Jung Won
    Kim, Byoung Mok
    Oh, Seak Hee
    Kim, Kyung Mo
    Lee, Inchul
    Im, Chang-Nim
    Liu, Jianjun
    McGovern, Dermot P. B.
    Yang, Suk-Kyun
    Song, Kyuyoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (12) : 2118 - 2125
  • [45] Duration of Crohn's disease does not influence patient's response to infliximab
    Weinberg, AM
    Lewis, JD
    Su, CG
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S254 - S254
  • [46] Mesenteric disease is directly related to mucosal disease in Crohn's disease
    Kiernan, M. G.
    Sahebally, S. M.
    Waldron, D.
    Moloney, M.
    Skelly, M.
    Hidayat, H.
    O'Leary, D. P.
    Lowery, A. J.
    Walsh, L. G.
    Dunne, C. P.
    Coffey, J. C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S186 - S187
  • [47] Mucosal healing in Crohn's disease: new insights
    Cucchiara, Salvatore
    D'Arcangelo, Giulia
    Isoldi, Sara
    Aloi, Marina
    Stronati, Laura
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 335 - 345
  • [48] Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
    Dorofeyev, A. E.
    Vasilenko, I. V.
    Rassokhina, O. A.
    Kondratiuk, R. B.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [49] Endoscopic and Mucosal Healing in Crohn's Disease with Azathioprine
    Nadir, Isilay
    Kafadar, Mehmet Tolga
    Kasapoglu, Benan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [50] Thalidomide Induces Mucosal Healing in Crohn's Disease
    Lazzerini, M.
    Maschio, M.
    Martelossi, S.
    Di Leo, D.
    Ventura, A.
    WCPGHAN 3: WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION, 2008, : 13 - +